CVRXCVRx, Inc.

Nasdaq cvrx.com


$ 8.41 $ -0.10 (-1.17 %)    

Friday, 06-Sep-2024 15:59:39 EDT
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 8.42
$ 8.40 x 100
-- x --
-- - --
$ 6.40 - $ 33.14
193,876
na
183.44M
$ 1.51
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-02-2024 06-30-2024 10-Q
2 05-10-2024 03-31-2024 10-Q
3 02-09-2024 12-31-2023 10-K
4 10-31-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 02-10-2023 12-31-2022 10-K
8 11-04-2022 09-30-2022 10-Q
9 08-01-2022 06-30-2022 10-Q
10 05-02-2022 03-31-2022 10-Q
11 02-22-2022 12-31-2021 10-K
12 11-08-2021 09-30-2021 10-Q
13 08-09-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 lake-street-reiterates-buy-on-cvrx-maintains-12-price-target

Lake Street analyst Frank Takkinen reiterates CVRx (NASDAQ:CVRX) with a Buy and maintains $12 price target.

 cvrx-announces-cms-reassignment-of-barostim-implant-procedure-to-ms-drg-276-with-43000-national-average-payment-in-fy-2025-medicare-hospital-inpatient-prospective-payment-system

New Payment Effective October 1, 2024

 piper-sandler-maintains-overweight-on-cvrx-lowers-price-target-to-13

Piper Sandler analyst Matt O'Brien maintains CVRx (NASDAQ:CVRX) with a Overweight and lowers the price target from $15 t...

 canaccord-genuity-maintains-buy-on-cvrx-raises-price-target-to-15

Canaccord Genuity analyst William Plovanic maintains CVRx (NASDAQ:CVRX) with a Buy and raises the price target from $14 to $15.

 cvrx-continues-to-expect-fy24-total-revenue-of-50m---53m-est-50803m

For the full year of 2024, the Company now expects: Total revenue between $50.0 million and $53.0 million; Gross margin bet...

 cvrx-q2-2024-gaap-eps-065-misses-053-estimate-sales-11807m-beat-11787m-estimate

CVRx (NASDAQ:CVRX) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.53) by 22....

 craig-hallum-maintains-buy-on-cvrx-lowers-price-target-to-15

Craig-Hallum analyst Alexander Nowak maintains CVRx (NASDAQ:CVRX) with a Buy and lowers the price target from $23 to $15.

 lake-street-maintains-buy-on-cvrx-lowers-price-target-to-12

Lake Street analyst Frank Takkinen maintains CVRx (NASDAQ:CVRX) with a Buy and lowers the price target from $18 to $12.

 lake-street-maintains-buy-on-cvrx-lowers-price-target-to-18

Lake Street analyst Frank Takkinen maintains CVRx (NASDAQ:CVRX) with a Buy and lowers the price target from $35 to $18.

 canaccord-genuity-maintains-buy-on-cvrx-lowers-price-target-to-14

Canaccord Genuity analyst William Plovanic maintains CVRx (NASDAQ:CVRX) with a Buy and lowers the price target from $32 to $14.

 craig-hallum-assumes-cvrx-at-buy-lowers-price-target-of-23

Craig-Hallum analyst Alexander Nowak assumes CVRx (NASDAQ:CVRX) with a Buy rating and lowers Price Target of $23.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION